

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | rRNA transcription (GO:0009303) | 9.15818067 |
| 2 | positive regulation of signal transduction by p53 class mediator (GO:1901798) | 8.82506480 |
| 3 | macroautophagy (GO:0016236) | 8.66886297 |
| 4 | induction of positive chemotaxis (GO:0050930) | 7.38905575 |
| 5 | positive regulation of vascular permeability (GO:0043117) | 6.83370397 |
| 6 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146) | 6.67631027 |
| 7 | UV protection (GO:0009650) | 5.66001312 |
| 8 | hair cell differentiation (GO:0035315) | 5.46445859 |
| 9 | myelin assembly (GO:0032288) | 5.29779595 |
| 10 | astrocyte differentiation (GO:0048708) | 5.25714218 |
| 11 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 5.13191783 |
| 12 | heart morphogenesis (GO:0003007) | 4.93799041 |
| 13 | erythrocyte maturation (GO:0043249) | 4.82285364 |
| 14 | regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516) | 4.79779397 |
| 15 | hematopoietic stem cell differentiation (GO:0060218) | 4.61040178 |
| 16 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.46726319 |
| 17 | meiotic chromosome segregation (GO:0045132) | 4.38533778 |
| 18 | spinal cord development (GO:0021510) | 4.31046677 |
| 19 | positive regulation of positive chemotaxis (GO:0050927) | 4.27572992 |
| 20 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.17493441 |
| 21 | regulation of positive chemotaxis (GO:0050926) | 4.08040632 |
| 22 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 4.07174431 |
| 23 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 4.05778686 |
| 24 | astrocyte development (GO:0014002) | 4.05670442 |
| 25 | positive regulation of defense response to virus by host (GO:0002230) | 4.00501670 |
| 26 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.91313166 |
| 27 | regulation of synapse maturation (GO:0090128) | 3.88296945 |
| 28 | protein targeting to lysosome (GO:0006622) | 3.75452338 |
| 29 | establishment of protein localization to vacuole (GO:0072666) | 3.75452338 |
| 30 | protein targeting to vacuole (GO:0006623) | 3.75452338 |
| 31 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.75017125 |
| 32 | plasma membrane repair (GO:0001778) | 3.67864032 |
| 33 | peroxisome organization (GO:0007031) | 3.56937361 |
| 34 | forebrain morphogenesis (GO:0048853) | 3.54904206 |
| 35 | lateral ventricle development (GO:0021670) | 3.53794010 |
| 36 | peroxisome fission (GO:0016559) | 3.51655606 |
| 37 | maintenance of protein location in nucleus (GO:0051457) | 3.51107117 |
| 38 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.50193725 |
| 39 | embryonic skeletal joint morphogenesis (GO:0060272) | 3.47039696 |
| 40 | chondroitin sulfate catabolic process (GO:0030207) | 3.43054381 |
| 41 | mitotic nuclear envelope reassembly (GO:0007084) | 3.42308894 |
| 42 | nuclear envelope reassembly (GO:0031468) | 3.42308894 |
| 43 | creatine metabolic process (GO:0006600) | 3.38062311 |
| 44 | carnitine metabolic process (GO:0009437) | 3.35611478 |
| 45 | resolution of meiotic recombination intermediates (GO:0000712) | 3.27280121 |
| 46 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.26205785 |
| 47 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.22619756 |
| 48 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.22221736 |
| 49 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.21676455 |
| 50 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.17266846 |
| 51 | sodium ion export (GO:0071436) | 3.14207352 |
| 52 | anatomical structure maturation (GO:0071695) | 3.13015231 |
| 53 | inositol phosphate-mediated signaling (GO:0048016) | 3.10097764 |
| 54 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.08201057 |
| 55 | glomerulus development (GO:0032835) | 3.07200384 |
| 56 | cellular potassium ion homeostasis (GO:0030007) | 3.06350937 |
| 57 | central nervous system myelination (GO:0022010) | 3.05832787 |
| 58 | axon ensheathment in central nervous system (GO:0032291) | 3.05832787 |
| 59 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 3.04168256 |
| 60 | positive regulation of protein targeting to membrane (GO:0090314) | 3.03479873 |
| 61 | energy homeostasis (GO:0097009) | 3.03392313 |
| 62 | regulation of monocyte chemotaxis (GO:0090025) | 3.00397940 |
| 63 | cytoplasmic sequestering of transcription factor (GO:0042994) | 2.98458660 |
| 64 | negative regulation of adherens junction organization (GO:1903392) | 2.97781688 |
| 65 | negative regulation of focal adhesion assembly (GO:0051895) | 2.97781688 |
| 66 | negative regulation of cell junction assembly (GO:1901889) | 2.97781688 |
| 67 | cellular response to pH (GO:0071467) | 2.97249753 |
| 68 | synaptonemal complex assembly (GO:0007130) | 2.97193627 |
| 69 | synaptic vesicle maturation (GO:0016188) | 2.93524093 |
| 70 | response to phenylpropanoid (GO:0080184) | 2.92280230 |
| 71 | regulation of translation in response to stress (GO:0043555) | 2.91664761 |
| 72 | cell communication by electrical coupling (GO:0010644) | 2.90932382 |
| 73 | reciprocal DNA recombination (GO:0035825) | 2.88336658 |
| 74 | reciprocal meiotic recombination (GO:0007131) | 2.88336658 |
| 75 | hemidesmosome assembly (GO:0031581) | 2.87708898 |
| 76 | sarcomere organization (GO:0045214) | 2.87548004 |
| 77 | protein localization to endosome (GO:0036010) | 2.85826864 |
| 78 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.83942760 |
| 79 | activation of protein kinase A activity (GO:0034199) | 2.83785381 |
| 80 | chaperone-mediated protein transport (GO:0072321) | 2.82167728 |
| 81 | tricarboxylic acid cycle (GO:0006099) | 2.82080672 |
| 82 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 2.81389586 |
| 83 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.79990872 |
| 84 | myoblast migration (GO:0051451) | 2.79499109 |
| 85 | cardiac myofibril assembly (GO:0055003) | 2.78541034 |
| 86 | hyaluronan catabolic process (GO:0030214) | 2.78169636 |
| 87 | JNK cascade (GO:0007254) | 2.77637294 |
| 88 | diacylglycerol metabolic process (GO:0046339) | 2.77050148 |
| 89 | iron-sulfur cluster assembly (GO:0016226) | 2.74871135 |
| 90 | metallo-sulfur cluster assembly (GO:0031163) | 2.74871135 |
| 91 | protein localization to vacuole (GO:0072665) | 2.73733533 |
| 92 | protein localization to lysosome (GO:0061462) | 2.73733533 |
| 93 | potassium ion import (GO:0010107) | 2.73532861 |
| 94 | negative regulation of macroautophagy (GO:0016242) | 2.72482947 |
| 95 | layer formation in cerebral cortex (GO:0021819) | 2.71705609 |
| 96 | muscle filament sliding (GO:0030049) | 2.70255432 |
| 97 | actin-myosin filament sliding (GO:0033275) | 2.70255432 |
| 98 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.69496750 |
| 99 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.68231823 |
| 100 | cysteine metabolic process (GO:0006534) | 2.67073668 |
| 101 | regulation of lymphocyte migration (GO:2000401) | 2.66162901 |
| 102 | histone H4 deacetylation (GO:0070933) | 2.65955533 |
| 103 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.64781739 |
| 104 | establishment of epithelial cell polarity (GO:0090162) | 2.64382405 |
| 105 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.64111156 |
| 106 | establishment of viral latency (GO:0019043) | 2.63387223 |
| 107 | locomotory exploration behavior (GO:0035641) | 2.63193927 |
| 108 | neuromuscular junction development (GO:0007528) | 2.63187804 |
| 109 | regulation of synapse structural plasticity (GO:0051823) | 2.62736845 |
| 110 | negative regulation of protein localization to cell surface (GO:2000009) | 2.62321202 |
| 111 | maintenance of protein localization in organelle (GO:0072595) | 2.62078871 |
| 112 | axon ensheathment (GO:0008366) | 2.61870708 |
| 113 | ensheathment of neurons (GO:0007272) | 2.61870708 |
| 114 | carnitine shuttle (GO:0006853) | 2.61379211 |
| 115 | cell communication involved in cardiac conduction (GO:0086065) | 2.59227711 |
| 116 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.58470888 |
| 117 | potassium ion homeostasis (GO:0055075) | 2.58223062 |
| 118 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.57120674 |
| 119 | nerve growth factor signaling pathway (GO:0038180) | 2.57070496 |
| 120 | myelin maintenance (GO:0043217) | 2.56594972 |
| 121 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.56416363 |
| 122 | myelination (GO:0042552) | 2.55884415 |
| 123 | synaptonemal complex organization (GO:0070193) | 2.55720906 |
| 124 | regulation of signal transduction by p53 class mediator (GO:1901796) | 2.55380942 |
| 125 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.54848624 |
| 126 | regulation of membrane repolarization (GO:0060306) | 2.54407992 |
| 127 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.52629045 |
| 128 | regulation of skeletal muscle contraction (GO:0014819) | 2.51977165 |
| 129 | cardiac muscle contraction (GO:0060048) | 2.51665582 |
| 130 | establishment of mitochondrion localization (GO:0051654) | 2.51428068 |
| 131 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872) | 2.51170256 |
| 132 | positive regulation of response to DNA damage stimulus (GO:2001022) | 2.49439881 |
| 133 | cell-cell junction maintenance (GO:0045217) | 2.48401759 |
| 134 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.48384934 |
| 135 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.48384934 |
| 136 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.47567530 |
| 137 | cerebellar Purkinje cell layer development (GO:0021680) | 2.47408215 |
| 138 | positive regulation of potassium ion transport (GO:0043268) | 2.45469518 |
| 139 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.45148822 |
| 140 | transcription from RNA polymerase I promoter (GO:0006360) | 2.44234680 |
| 141 | regulation of protein polyubiquitination (GO:1902914) | 2.44075334 |
| 142 | membrane tubulation (GO:0097320) | 2.42971338 |
| 143 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.42487012 |
| 144 | early endosome to late endosome transport (GO:0045022) | 2.41472959 |
| 145 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.40824712 |
| 146 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.40670057 |
| 147 | dendrite morphogenesis (GO:0048813) | 2.39470186 |
| 148 | sperm capacitation (GO:0048240) | 2.38566619 |
| 149 | thrombin receptor signaling pathway (GO:0070493) | 2.38394493 |
| 150 | myofibril assembly (GO:0030239) | 2.38244919 |
| 151 | amino-acid betaine metabolic process (GO:0006577) | 2.37739610 |
| 152 | negative regulation of inclusion body assembly (GO:0090084) | 2.36732775 |
| 153 | membrane repolarization (GO:0086009) | 2.36102429 |
| 154 | glutamate secretion (GO:0014047) | 2.34197443 |
| 155 | negative regulation of organelle assembly (GO:1902116) | 2.33706887 |
| 156 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.32192830 |
| 157 | mating behavior (GO:0007617) | 2.32022327 |
| 158 | membrane repolarization during action potential (GO:0086011) | 2.31658342 |
| 159 | acyl-CoA biosynthetic process (GO:0071616) | 2.30562795 |
| 160 | thioester biosynthetic process (GO:0035384) | 2.30562795 |
| 161 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.27365571 |
| 162 | protein targeting to Golgi (GO:0000042) | 2.26908891 |
| 163 | aspartate family amino acid catabolic process (GO:0009068) | 2.25851223 |
| 164 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.24716634 |
| 165 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.24493009 |
| 166 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.23736857 |
| 167 | protein targeting to plasma membrane (GO:0072661) | 2.23667108 |
| 168 | cellular sodium ion homeostasis (GO:0006883) | 2.23141086 |
| 169 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.22965471 |
| 170 | negative regulation of cell size (GO:0045792) | 2.21475683 |
| 171 | actomyosin structure organization (GO:0031032) | 2.20875812 |
| 172 | carnitine transmembrane transport (GO:1902603) | 2.20154151 |
| 173 | establishment of protein localization to Golgi (GO:0072600) | 2.19830167 |
| 174 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.19619746 |
| 175 | actin-mediated cell contraction (GO:0070252) | 2.18676520 |
| 176 | apical protein localization (GO:0045176) | 2.16983286 |
| 177 | amino-acid betaine transport (GO:0015838) | 2.16192923 |
| 178 | carnitine transport (GO:0015879) | 2.16192923 |
| 179 | stress fiber assembly (GO:0043149) | 2.15932833 |
| 180 | dendritic spine morphogenesis (GO:0060997) | 2.15214479 |
| 181 | neuronal action potential propagation (GO:0019227) | 2.14663764 |
| 182 | response to methylmercury (GO:0051597) | 2.14111561 |
| 183 | membrane depolarization during action potential (GO:0086010) | 2.12632647 |
| 184 | establishment of nucleus localization (GO:0040023) | 2.11772080 |
| 185 | fatty acid elongation (GO:0030497) | 2.11679172 |
| 186 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.11598388 |
| 187 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.11294620 |
| 188 | vocalization behavior (GO:0071625) | 2.11202466 |
| 189 | fatty acid transmembrane transport (GO:1902001) | 2.10524315 |
| 190 | neuromuscular process controlling balance (GO:0050885) | 2.09627156 |
| 191 | asymmetric protein localization (GO:0008105) | 2.09153177 |
| 192 | camera-type eye morphogenesis (GO:0048593) | 2.08827462 |
| 193 | synaptic vesicle exocytosis (GO:0016079) | 2.08187273 |
| 194 | relaxation of cardiac muscle (GO:0055119) | 2.06845316 |
| 195 | regulation of cell communication by electrical coupling (GO:0010649) | 2.06306902 |
| 196 | activation of MAPKKK activity (GO:0000185) | 17.1947572 |
| 197 | leukocyte aggregation (GO:0070486) | 11.3965687 |
| 198 | glycoprotein catabolic process (GO:0006516) | 11.3634205 |
| 199 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 10.5969241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.65186573 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.54034591 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.89225351 |
| 4 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.19719631 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.18900553 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.18371420 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.17085389 |
| 8 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 2.13873545 |
| 9 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.11827958 |
| 10 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 2.08819724 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.06703768 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.05572743 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.02592832 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.00786131 |
| 15 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.00551139 |
| 16 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.99261322 |
| 17 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.99088979 |
| 18 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.98185304 |
| 19 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.96716954 |
| 20 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.96486830 |
| 21 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.96486830 |
| 22 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.89366028 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.81756521 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.80318553 |
| 25 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.78798546 |
| 26 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.78638101 |
| 27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.78129076 |
| 28 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.77415912 |
| 29 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.76648376 |
| 30 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.73948811 |
| 31 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.73784660 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.72158814 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.68259998 |
| 34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.66762319 |
| 35 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.65870713 |
| 36 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.62208953 |
| 37 | P68_20966046_ChIP-Seq_HELA_Human | 1.60880900 |
| 38 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.59836298 |
| 39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59561049 |
| 40 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.58173508 |
| 41 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.56981540 |
| 42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.56414003 |
| 43 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.56327628 |
| 44 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.55682605 |
| 45 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.53549666 |
| 46 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.53456883 |
| 47 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.50355304 |
| 48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.49317736 |
| 49 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.46838284 |
| 50 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.46138339 |
| 51 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.45989168 |
| 52 | KDM2B_26808549_Chip-Seq_K562_Human | 1.44553734 |
| 53 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.42454093 |
| 54 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.42166187 |
| 55 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.41631813 |
| 56 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.37810383 |
| 57 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.37810383 |
| 58 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.37440711 |
| 59 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.37018724 |
| 60 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.35909115 |
| 61 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.35315673 |
| 62 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.34909805 |
| 63 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.34858874 |
| 64 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.34731790 |
| 65 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.33914104 |
| 66 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.33034587 |
| 67 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.32341034 |
| 68 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.32111055 |
| 69 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30386903 |
| 70 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29023567 |
| 71 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.27491843 |
| 72 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25743283 |
| 73 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.25213666 |
| 74 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.24245769 |
| 75 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.19309895 |
| 76 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.19148985 |
| 77 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.19105905 |
| 78 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.18159635 |
| 79 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17953482 |
| 80 | TP53_16413492_ChIP-PET_HCT116_Human | 1.17399834 |
| 81 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.15581481 |
| 82 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.15240190 |
| 83 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14050649 |
| 84 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.12817885 |
| 85 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.12161856 |
| 86 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.11064910 |
| 87 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.07914362 |
| 88 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.07303175 |
| 89 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.06827012 |
| 90 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05432839 |
| 91 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.05192199 |
| 92 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04485275 |
| 93 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.02940821 |
| 94 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02392614 |
| 95 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.02365393 |
| 96 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.00736023 |
| 97 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.00189701 |
| 98 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99959224 |
| 99 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.99505829 |
| 100 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.99490762 |
| 101 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.99144168 |
| 102 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.99034204 |
| 103 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.98906145 |
| 104 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97338333 |
| 105 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97159659 |
| 106 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.96963955 |
| 107 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.96060936 |
| 108 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.95952261 |
| 109 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95632620 |
| 110 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.95419222 |
| 111 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94949284 |
| 112 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94682994 |
| 113 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94097850 |
| 114 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.93700914 |
| 115 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93401079 |
| 116 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93225157 |
| 117 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.93179309 |
| 118 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.92994346 |
| 119 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.92861964 |
| 120 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.92188857 |
| 121 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.91937247 |
| 122 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91926823 |
| 123 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91617799 |
| 124 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.91602424 |
| 125 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91532755 |
| 126 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.91468363 |
| 127 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.91090701 |
| 128 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.91090701 |
| 129 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89375071 |
| 130 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.89063619 |
| 131 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.88746115 |
| 132 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88693234 |
| 133 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.88479969 |
| 134 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.88460064 |
| 135 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.88060871 |
| 136 | AR_19668381_ChIP-Seq_PC3_Human | 0.87367191 |
| 137 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.86743235 |
| 138 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.86135948 |
| 139 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.85763443 |
| 140 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.84737282 |
| 141 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84601878 |
| 142 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.84245329 |
| 143 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.84231071 |
| 144 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82219286 |
| 145 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.82070506 |
| 146 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.81285391 |
| 147 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80767929 |
| 148 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.80659098 |
| 149 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.80413355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000751_myopathy | 3.51271393 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 3.19260086 |
| 3 | MP0002938_white_spotting | 3.01157818 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 2.84915274 |
| 5 | MP0004145_abnormal_muscle_electrophysio | 2.77999140 |
| 6 | MP0000858_altered_metastatic_potential | 2.76194379 |
| 7 | MP0003385_abnormal_body_wall | 2.71182877 |
| 8 | MP0003786_premature_aging | 2.65117432 |
| 9 | MP0004036_abnormal_muscle_relaxation | 2.63220125 |
| 10 | MP0004084_abnormal_cardiac_muscle | 2.56413386 |
| 11 | MP0000747_muscle_weakness | 2.50521092 |
| 12 | MP0003283_abnormal_digestive_organ | 2.37347459 |
| 13 | MP0004270_analgesia | 2.37326516 |
| 14 | MP0000749_muscle_degeneration | 2.35466365 |
| 15 | MP0003329_amyloid_beta_deposits | 2.24636085 |
| 16 | MP0005623_abnormal_meninges_morphology | 2.23695657 |
| 17 | MP0008438_abnormal_cutaneous_collagen | 2.20677935 |
| 18 | MP0004947_skin_inflammation | 2.11438082 |
| 19 | MP0000013_abnormal_adipose_tissue | 2.09738417 |
| 20 | MP0005410_abnormal_fertilization | 2.00538031 |
| 21 | MP0004233_abnormal_muscle_weight | 1.96293646 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 1.86698253 |
| 23 | * MP0004087_abnormal_muscle_fiber | 1.85191879 |
| 24 | MP0004130_abnormal_muscle_cell | 1.84499820 |
| 25 | MP0003635_abnormal_synaptic_transmissio | 1.80948248 |
| 26 | MP0002638_abnormal_pupillary_reflex | 1.80544325 |
| 27 | MP0005330_cardiomyopathy | 1.78551752 |
| 28 | MP0010307_abnormal_tumor_latency | 1.72025765 |
| 29 | MP0004043_abnormal_pH_regulation | 1.71886772 |
| 30 | MP0003115_abnormal_respiratory_system | 1.71243798 |
| 31 | MP0004215_abnormal_myocardial_fiber | 1.68634382 |
| 32 | MP0002822_catalepsy | 1.66409867 |
| 33 | * MP0002269_muscular_atrophy | 1.63023548 |
| 34 | MP0002909_abnormal_adrenal_gland | 1.62169091 |
| 35 | MP0000920_abnormal_myelination | 1.60262079 |
| 36 | MP0000003_abnormal_adipose_tissue | 1.59131220 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.58818990 |
| 38 | MP0005620_abnormal_muscle_contractility | 1.55345184 |
| 39 | MP0002177_abnormal_outer_ear | 1.54206812 |
| 40 | * MP0000759_abnormal_skeletal_muscle | 1.53290794 |
| 41 | MP0004858_abnormal_nervous_system | 1.48628815 |
| 42 | MP0003137_abnormal_impulse_conducting | 1.47689396 |
| 43 | MP0004185_abnormal_adipocyte_glucose | 1.46924288 |
| 44 | * MP0002106_abnormal_muscle_physiology | 1.45091180 |
| 45 | MP0005375_adipose_tissue_phenotype | 1.41933752 |
| 46 | MP0004885_abnormal_endolymph | 1.40706949 |
| 47 | MP0005666_abnormal_adipose_tissue | 1.39753722 |
| 48 | MP0002064_seizures | 1.37275127 |
| 49 | MP0004272_abnormal_basement_membrane | 1.31795644 |
| 50 | MP0003646_muscle_fatigue | 1.31541220 |
| 51 | MP0002972_abnormal_cardiac_muscle | 1.30926110 |
| 52 | MP0002063_abnormal_learning/memory/cond | 1.28992772 |
| 53 | MP0002272_abnormal_nervous_system | 1.28858556 |
| 54 | MP0003880_abnormal_central_pattern | 1.27303748 |
| 55 | * MP0005369_muscle_phenotype | 1.27301401 |
| 56 | MP0003950_abnormal_plasma_membrane | 1.27242553 |
| 57 | MP0001299_abnormal_eye_distance/ | 1.25609723 |
| 58 | MP0001958_emphysema | 1.25565450 |
| 59 | MP0009745_abnormal_behavioral_response | 1.25187480 |
| 60 | * MP0000750_abnormal_muscle_regeneration | 1.23375936 |
| 61 | MP0004085_abnormal_heartbeat | 1.22798835 |
| 62 | MP0002234_abnormal_pharynx_morphology | 1.22006163 |
| 63 | MP0003634_abnormal_glial_cell | 1.21436776 |
| 64 | MP0009379_abnormal_foot_pigmentation | 1.18608033 |
| 65 | MP0002734_abnormal_mechanical_nocicepti | 1.14880448 |
| 66 | MP0008775_abnormal_heart_ventricle | 1.13568852 |
| 67 | MP0009046_muscle_twitch | 1.12185417 |
| 68 | MP0002295_abnormal_pulmonary_circulatio | 1.11839192 |
| 69 | MP0010234_abnormal_vibrissa_follicle | 1.10467085 |
| 70 | MP0004484_altered_response_of | 1.08427100 |
| 71 | MP0010630_abnormal_cardiac_muscle | 1.07489230 |
| 72 | MP0005257_abnormal_intraocular_pressure | 1.06930875 |
| 73 | MP0003633_abnormal_nervous_system | 1.06897048 |
| 74 | MP0003755_abnormal_palate_morphology | 1.05147235 |
| 75 | MP0001765_abnormal_ion_homeostasis | 1.04636147 |
| 76 | MP0000537_abnormal_urethra_morphology | 1.03826578 |
| 77 | MP0006138_congestive_heart_failure | 1.03823308 |
| 78 | MP0005670_abnormal_white_adipose | 1.03190184 |
| 79 | MP0001440_abnormal_grooming_behavior | 1.03052163 |
| 80 | MP0005275_abnormal_skin_tensile | 1.01718460 |
| 81 | MP0005167_abnormal_blood-brain_barrier | 1.01703045 |
| 82 | MP0000462_abnormal_digestive_system | 0.96494743 |
| 83 | MP0003690_abnormal_glial_cell | 0.95869647 |
| 84 | MP0003279_aneurysm | 0.95406892 |
| 85 | MP0005083_abnormal_biliary_tract | 0.95123338 |
| 86 | MP0004147_increased_porphyrin_level | 0.94637251 |
| 87 | MP0000733_abnormal_muscle_development | 0.94467041 |
| 88 | MP0002108_abnormal_muscle_morphology | 0.93788838 |
| 89 | MP0000955_abnormal_spinal_cord | 0.93099922 |
| 90 | MP0008569_lethality_at_weaning | 0.92531854 |
| 91 | MP0005508_abnormal_skeleton_morphology | 0.91923036 |
| 92 | MP0000778_abnormal_nervous_system | 0.91457763 |
| 93 | MP0001486_abnormal_startle_reflex | 0.90762250 |
| 94 | MP0002572_abnormal_emotion/affect_behav | 0.90713859 |
| 95 | MP0001502_abnormal_circadian_rhythm | 0.90474209 |
| 96 | MP0000604_amyloidosis | 0.89726534 |
| 97 | MP0008961_abnormal_basal_metabolism | 0.88837082 |
| 98 | MP0003631_nervous_system_phenotype | 0.88218087 |
| 99 | MP0003221_abnormal_cardiomyocyte_apopto | 0.87787623 |
| 100 | MP0002896_abnormal_bone_mineralization | 0.87701201 |
| 101 | MP0000534_abnormal_ureter_morphology | 0.87602264 |
| 102 | MP0005171_absent_coat_pigmentation | 0.87431452 |
| 103 | MP0002090_abnormal_vision | 0.87379664 |
| 104 | MP0005385_cardiovascular_system_phenoty | 0.87085726 |
| 105 | MP0001544_abnormal_cardiovascular_syste | 0.87085726 |
| 106 | MP0009384_cardiac_valve_regurgitation | 0.87077770 |
| 107 | MP0000343_altered_response_to | 0.85558073 |
| 108 | MP0003566_abnormal_cell_adhesion | 0.84958085 |
| 109 | * MP0002066_abnormal_motor_capabilities/c | 0.84394401 |
| 110 | MP0010030_abnormal_orbit_morphology | 0.83516483 |
| 111 | MP0002089_abnormal_postnatal_growth/wei | 0.82902488 |
| 112 | MP0005423_abnormal_somatic_nervous | 0.81443443 |
| 113 | MP0004811_abnormal_neuron_physiology | 0.79910084 |
| 114 | MP0004924_abnormal_behavior | 0.79208104 |
| 115 | MP0005386_behavior/neurological_phenoty | 0.79208104 |
| 116 | MP0002733_abnormal_thermal_nociception | 0.79080956 |
| 117 | MP0002229_neurodegeneration | 0.79034564 |
| 118 | MP0002933_joint_inflammation | 0.78649656 |
| 119 | MP0003045_fibrosis | 0.78217709 |
| 120 | * MP0002882_abnormal_neuron_morphology | 0.77869713 |
| 121 | MP0010352_gastrointestinal_tract_polyps | 0.77071920 |
| 122 | MP0009250_abnormal_appendicular_skeleto | 0.75971580 |
| 123 | MP0001970_abnormal_pain_threshold | 0.75281697 |
| 124 | MP0003632_abnormal_nervous_system | 0.74722023 |
| 125 | MP0002114_abnormal_axial_skeleton | 0.72768077 |
| 126 | MP0005503_abnormal_tendon_morphology | 0.72732626 |
| 127 | MP0002249_abnormal_larynx_morphology | 0.71687957 |
| 128 | MP0000579_abnormal_nail_morphology | 0.70806037 |
| 129 | MP0003879_abnormal_hair_cell | 0.65312713 |
| 130 | MP0010368_abnormal_lymphatic_system | 0.64375518 |
| 131 | MP0003935_abnormal_craniofacial_develop | 0.63724459 |
| 132 | MP0002128_abnormal_blood_circulation | 0.62664346 |
| 133 | MP0005193_abnormal_anterior_eye | 0.62437719 |
| 134 | MP0002116_abnormal_craniofacial_bone | 0.61794374 |
| 135 | MP0005621_abnormal_cell_physiology | 0.61484214 |
| 136 | MP0006054_spinal_hemorrhage | 0.60499190 |
| 137 | MP0003453_abnormal_keratinocyte_physiol | 0.58416818 |
| 138 | MP0002877_abnormal_melanocyte_morpholog | 0.55761983 |
| 139 | MP0005165_increased_susceptibility_to | 0.53406498 |
| 140 | MP0008874_decreased_physiological_sensi | 0.50934608 |
| 141 | MP0002163_abnormal_gland_morphology | 0.49921634 |
| 142 | MP0002113_abnormal_skeleton_development | 0.48389983 |
| 143 | MP0005408_hypopigmentation | 0.47064423 |
| 144 | MP0001175_abnormal_lung_morphology | 0.46941906 |
| 145 | MP0004197_abnormal_fetal_growth/weight/ | 0.46730288 |
| 146 | MP0005164_abnormal_response_to | 0.46433478 |
| 147 | MP0005197_abnormal_uvea_morphology | 0.46261558 |
| 148 | MP0005379_endocrine/exocrine_gland_phen | 0.46003199 |
| 149 | MP0000377_abnormal_hair_follicle | 0.44306489 |
| 150 | MP0005332_abnormal_amino_acid | 0.41904378 |
| 151 | MP0005501_abnormal_skin_physiology | 0.41268249 |
| 152 | * MP0000762_abnormal_tongue_morphology | 0.40469348 |
| 153 | MP0000467_abnormal_esophagus_morphology | 0.40337933 |
| 154 | MP0001915_intracranial_hemorrhage | 0.40064542 |
| 155 | MP0005023_abnormal_wound_healing | 0.39673692 |
| 156 | MP0005384_cellular_phenotype | 0.37823228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Entropion (HP:0000621) | 8.46881979 |
| 2 | Poikiloderma (HP:0001029) | 6.27127641 |
| 3 | Fragile nails (HP:0001808) | 5.71444212 |
| 4 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 5.47832357 |
| 5 | Decreased subcutaneous fat (HP:0001002) | 5.27947796 |
| 6 | Mesangial abnormality (HP:0001966) | 5.23765798 |
| 7 | Abnormality of DNA repair (HP:0003254) | 4.95962349 |
| 8 | Rectal prolapse (HP:0002035) | 4.27481533 |
| 9 | Exercise-induced myalgia (HP:0003738) | 4.16672451 |
| 10 | Submucous cleft hard palate (HP:0000176) | 4.13918788 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 3.92176378 |
| 12 | Abnormality of subcutaneous fat tissue (HP:0001001) | 3.83975753 |
| 13 | Papilledema (HP:0001085) | 3.76654453 |
| 14 | Brittle hair (HP:0002299) | 3.76506193 |
| 15 | Slow saccadic eye movements (HP:0000514) | 3.70519228 |
| 16 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.58070775 |
| 17 | Muscle fiber splitting (HP:0003555) | 3.52788737 |
| 18 | IgG deficiency (HP:0004315) | 3.46234078 |
| 19 | Difficulty running (HP:0009046) | 3.40193085 |
| 20 | Exercise-induced muscle cramps (HP:0003710) | 3.37711530 |
| 21 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.34589463 |
| 22 | Sudden death (HP:0001699) | 3.30665431 |
| 23 | Calf muscle hypertrophy (HP:0008981) | 3.30596403 |
| 24 | Termporal pattern (HP:0011008) | 3.25018848 |
| 25 | Insidious onset (HP:0003587) | 3.25018848 |
| 26 | Ileus (HP:0002595) | 3.21555316 |
| 27 | Increased IgM level (HP:0003496) | 3.18727212 |
| 28 | Sacral dimple (HP:0000960) | 3.18322315 |
| 29 | Increased variability in muscle fiber diameter (HP:0003557) | 3.18167972 |
| 30 | Cerebral inclusion bodies (HP:0100314) | 3.18037100 |
| 31 | Erythroderma (HP:0001019) | 3.17503892 |
| 32 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.17218639 |
| 33 | Ectropion (HP:0000656) | 3.15040659 |
| 34 | Prominent metopic ridge (HP:0005487) | 3.13548682 |
| 35 | Death in childhood (HP:0003819) | 3.12712245 |
| 36 | Neurofibrillary tangles (HP:0002185) | 3.11737768 |
| 37 | Cerebral hypomyelination (HP:0006808) | 3.04476700 |
| 38 | Type 1 muscle fiber predominance (HP:0003803) | 3.04078743 |
| 39 | Cone-rod dystrophy (HP:0000548) | 2.97663594 |
| 40 | Myoglobinuria (HP:0002913) | 2.96373629 |
| 41 | Omphalocele (HP:0001539) | 2.96183987 |
| 42 | Keratitis (HP:0000491) | 2.95985020 |
| 43 | Abnormality of the calf musculature (HP:0001430) | 2.92736354 |
| 44 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.92588677 |
| 45 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.87565785 |
| 46 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.84853427 |
| 47 | Akinesia (HP:0002304) | 2.81097937 |
| 48 | Conical tooth (HP:0000698) | 2.74978191 |
| 49 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.70858219 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.70858219 |
| 51 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.67469500 |
| 52 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.67469500 |
| 53 | Supranuclear gaze palsy (HP:0000605) | 2.67177519 |
| 54 | Abnormality of the metopic suture (HP:0005556) | 2.67052605 |
| 55 | Bundle branch block (HP:0011710) | 2.66058142 |
| 56 | Muscle fiber inclusion bodies (HP:0100299) | 2.65548834 |
| 57 | EMG: myopathic abnormalities (HP:0003458) | 2.65002571 |
| 58 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.63964002 |
| 59 | Premature rupture of membranes (HP:0001788) | 2.53799520 |
| 60 | Achilles tendon contracture (HP:0001771) | 2.53261523 |
| 61 | Increased connective tissue (HP:0009025) | 2.48921164 |
| 62 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.47931851 |
| 63 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.47931851 |
| 64 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.47931851 |
| 65 | Myotonia (HP:0002486) | 2.43583028 |
| 66 | Abnormal albumin level (HP:0012116) | 2.40919086 |
| 67 | Hypoalbuminemia (HP:0003073) | 2.40919086 |
| 68 | * Difficulty climbing stairs (HP:0003551) | 2.39624406 |
| 69 | Scapular winging (HP:0003691) | 2.38729670 |
| 70 | Visual hallucinations (HP:0002367) | 2.37724433 |
| 71 | Ankyloglossia (HP:0010296) | 2.37098708 |
| 72 | Myokymia (HP:0002411) | 2.35137387 |
| 73 | Round ear (HP:0100830) | 2.33110600 |
| 74 | Upper limb amyotrophy (HP:0009129) | 2.31633133 |
| 75 | Distal upper limb amyotrophy (HP:0007149) | 2.31633133 |
| 76 | Nemaline bodies (HP:0003798) | 2.30371398 |
| 77 | Asymmetric septal hypertrophy (HP:0001670) | 2.27816488 |
| 78 | Abnormality of the Achilles tendon (HP:0005109) | 2.27761328 |
| 79 | Abnormality of incisor morphology (HP:0011063) | 2.27450792 |
| 80 | Abnormality of the corticospinal tract (HP:0002492) | 2.27006342 |
| 81 | Pheochromocytoma (HP:0002666) | 2.26771088 |
| 82 | Breast hypoplasia (HP:0003187) | 2.24855518 |
| 83 | Ankle clonus (HP:0011448) | 2.23556018 |
| 84 | Rocker bottom foot (HP:0001838) | 2.22637502 |
| 85 | Focal segmental glomerulosclerosis (HP:0000097) | 2.20804317 |
| 86 | Ventricular fibrillation (HP:0001663) | 2.19958979 |
| 87 | Vertebral arch anomaly (HP:0008438) | 2.19163875 |
| 88 | Abnormality of saccadic eye movements (HP:0000570) | 2.18315171 |
| 89 | Rapidly progressive (HP:0003678) | 2.17462621 |
| 90 | Prolonged QT interval (HP:0001657) | 2.17281253 |
| 91 | Thick nail (HP:0001805) | 2.15970807 |
| 92 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.15219621 |
| 93 | Brushfield spots (HP:0001088) | 2.14832573 |
| 94 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.13035700 |
| 95 | * Buphthalmos (HP:0000557) | 2.12261733 |
| 96 | Hemorrhage of the eye (HP:0011885) | 2.11069075 |
| 97 | Muscle stiffness (HP:0003552) | 2.09191297 |
| 98 | Protrusio acetabuli (HP:0003179) | 2.04846024 |
| 99 | Syncope (HP:0001279) | 2.04094739 |
| 100 | Diastasis recti (HP:0001540) | 2.02277523 |
| 101 | * Gowers sign (HP:0003391) | 2.01971979 |
| 102 | Myopathic facies (HP:0002058) | 2.01835510 |
| 103 | Broad metatarsal (HP:0001783) | 2.00582720 |
| 104 | Ridged nail (HP:0001807) | 1.98566941 |
| 105 | Distal arthrogryposis (HP:0005684) | 1.98264337 |
| 106 | Eosinophilia (HP:0001880) | 1.98112272 |
| 107 | Atrophic scars (HP:0001075) | 1.97980542 |
| 108 | Urinary urgency (HP:0000012) | 1.97654371 |
| 109 | Limb-girdle muscle atrophy (HP:0003797) | 1.96452961 |
| 110 | Right ventricular cardiomyopathy (HP:0011663) | 1.94981714 |
| 111 | Arthrogryposis multiplex congenita (HP:0002804) | 1.93680281 |
| 112 | Ventricular arrhythmia (HP:0004308) | 1.92738806 |
| 113 | Blue sclerae (HP:0000592) | 1.91199868 |
| 114 | Nephropathy (HP:0000112) | 1.91038611 |
| 115 | Increased serum pyruvate (HP:0003542) | 1.91019618 |
| 116 | Action tremor (HP:0002345) | 1.89481918 |
| 117 | Lower limb amyotrophy (HP:0007210) | 1.89372124 |
| 118 | Neuroendocrine neoplasm (HP:0100634) | 1.88250085 |
| 119 | Depressed nasal tip (HP:0000437) | 1.88238181 |
| 120 | Spinal rigidity (HP:0003306) | 1.88130999 |
| 121 | Abnormality of oral frenula (HP:0000190) | 1.86732144 |
| 122 | Cerebral aneurysm (HP:0004944) | 1.85921662 |
| 123 | Neck muscle weakness (HP:0000467) | 1.85904683 |
| 124 | Synostosis of carpal bones (HP:0005048) | 1.84582012 |
| 125 | Hypobetalipoproteinemia (HP:0003563) | 1.84523639 |
| 126 | Megalencephaly (HP:0001355) | 1.82109537 |
| 127 | Abnormality of the acetabulum (HP:0003170) | 1.81419796 |
| 128 | Atrial fibrillation (HP:0005110) | 1.81382118 |
| 129 | Foot dorsiflexor weakness (HP:0009027) | 1.80637912 |
| 130 | Ventricular tachycardia (HP:0004756) | 1.80558108 |
| 131 | Abdominal situs inversus (HP:0003363) | 1.78808337 |
| 132 | Abnormality of abdominal situs (HP:0011620) | 1.78808337 |
| 133 | Shallow orbits (HP:0000586) | 1.77994074 |
| 134 | Heart block (HP:0012722) | 1.77765747 |
| 135 | Lower limb muscle weakness (HP:0007340) | 1.77022665 |
| 136 | Abnormality of glycolysis (HP:0004366) | 1.76887043 |
| 137 | Primary atrial arrhythmia (HP:0001692) | 1.75905983 |
| 138 | Aplasia involving bones of the extremities (HP:0009825) | 1.75135467 |
| 139 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.75135467 |
| 140 | Aplasia of the phalanges of the hand (HP:0009802) | 1.75135467 |
| 141 | Stridor (HP:0010307) | 1.74821557 |
| 142 | Abnormality of the foot musculature (HP:0001436) | 1.74697597 |
| 143 | EMG: neuropathic changes (HP:0003445) | 1.74363280 |
| 144 | Abnormal atrioventricular conduction (HP:0005150) | 1.73558273 |
| 145 | Decreased muscle mass (HP:0003199) | 1.73146838 |
| 146 | Ketoacidosis (HP:0001993) | 1.73022727 |
| 147 | Delusions (HP:0000746) | 1.72223684 |
| 148 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.71980896 |
| 149 | Increased circulating renin level (HP:0000848) | 1.71955137 |
| 150 | Hammertoe (HP:0001765) | 1.70839280 |
| 151 | Focal seizures (HP:0007359) | 1.70750569 |
| 152 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.68565354 |
| 153 | Delayed cranial suture closure (HP:0000270) | 1.68267759 |
| 154 | Onion bulb formation (HP:0003383) | 1.67761083 |
| 155 | Spastic gait (HP:0002064) | 1.67743796 |
| 156 | Abnormality of the right ventricle (HP:0001707) | 1.67159803 |
| 157 | Supraventricular arrhythmia (HP:0005115) | 1.67063195 |
| 158 | Diminished movement (HP:0002374) | 1.66614797 |
| 159 | Stage 5 chronic kidney disease (HP:0003774) | 1.66521223 |
| 160 | Athetosis (HP:0002305) | 1.64676604 |
| 161 | Lipoatrophy (HP:0100578) | 1.64571321 |
| 162 | Intention tremor (HP:0002080) | 1.63768027 |
| 163 | Supraventricular tachycardia (HP:0004755) | 1.63412767 |
| 164 | Diaphragmatic weakness (HP:0009113) | 1.63289078 |
| 165 | Distal lower limb amyotrophy (HP:0008944) | 1.62350830 |
| 166 | Rhabdomyolysis (HP:0003201) | 1.62311194 |
| 167 | Abnormal cortical bone morphology (HP:0003103) | 1.61870350 |
| 168 | Hand muscle atrophy (HP:0009130) | 1.61663595 |
| 169 | Bladder diverticulum (HP:0000015) | 1.61388708 |
| 170 | Insomnia (HP:0100785) | 1.61342945 |
| 171 | Hypoplastic nipples (HP:0002557) | 1.60790980 |
| 172 | Glomerulosclerosis (HP:0000096) | 1.60644532 |
| 173 | Hamartoma of the eye (HP:0010568) | 1.60289417 |
| 174 | Conjunctival telangiectasia (HP:0000524) | 1.60004295 |
| 175 | Scrotal hypoplasia (HP:0000046) | 1.59836204 |
| 176 | Resting tremor (HP:0002322) | 1.59809531 |
| 177 | Craniofacial dystonia (HP:0012179) | 1.59481943 |
| 178 | Cholelithiasis (HP:0001081) | 1.58900277 |
| 179 | * Type II lissencephaly (HP:0007260) | 1.58305423 |
| 180 | Abnormality of the lower motor neuron (HP:0002366) | 1.57433382 |
| 181 | Atrioventricular block (HP:0001678) | 1.57132378 |
| 182 | Supernumerary ribs (HP:0005815) | 1.55649799 |
| 183 | Choreoathetosis (HP:0001266) | 1.53111199 |
| 184 | Spastic paraplegia (HP:0001258) | 1.52047833 |
| 185 | Tubulointerstitial fibrosis (HP:0005576) | 1.48915421 |
| 186 | Personality changes (HP:0000751) | 1.48820418 |
| 187 | Vertebral compression fractures (HP:0002953) | 1.48175383 |
| 188 | Focal dystonia (HP:0004373) | 1.47249250 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK10 | 9.06513885 |
| 2 | MARK3 | 8.94172597 |
| 3 | STK11 | 3.23232490 |
| 4 | TRIB3 | 3.16472290 |
| 5 | STK39 | 3.06230529 |
| 6 | TTN | 2.91081701 |
| 7 | PIM1 | 2.81394674 |
| 8 | PDK3 | 2.67382898 |
| 9 | PDK4 | 2.67382898 |
| 10 | PRKD3 | 2.43454073 |
| 11 | WNK4 | 2.37450721 |
| 12 | PHKG2 | 2.18255960 |
| 13 | PHKG1 | 2.18255960 |
| 14 | MAP3K9 | 2.17269170 |
| 15 | PKN2 | 2.09234052 |
| 16 | KSR2 | 1.87865938 |
| 17 | NTRK1 | 1.86864327 |
| 18 | EPHB1 | 1.75832855 |
| 19 | OXSR1 | 1.74780286 |
| 20 | ICK | 1.70686452 |
| 21 | PAK6 | 1.67127510 |
| 22 | LMTK2 | 1.55582207 |
| 23 | PDK2 | 1.51858125 |
| 24 | EPHA4 | 1.51163922 |
| 25 | BCKDK | 1.48518767 |
| 26 | PAK3 | 1.45809778 |
| 27 | NLK | 1.45795523 |
| 28 | MAP3K13 | 1.44699541 |
| 29 | DMPK | 1.42200085 |
| 30 | OBSCN | 1.39286643 |
| 31 | NTRK3 | 1.37936805 |
| 32 | CAMK1G | 1.35822371 |
| 33 | EPHA3 | 1.33729132 |
| 34 | DDR2 | 1.33653003 |
| 35 | RIPK1 | 1.31256187 |
| 36 | MET | 1.30888654 |
| 37 | PNCK | 1.29916436 |
| 38 | PDGFRA | 1.27266631 |
| 39 | PTK2B | 1.25107829 |
| 40 | TXK | 1.24066451 |
| 41 | MAP3K4 | 1.21468848 |
| 42 | CAMKK1 | 1.16941979 |
| 43 | TYRO3 | 1.16481202 |
| 44 | MARK1 | 1.14643876 |
| 45 | EPHA2 | 1.13494328 |
| 46 | RET | 1.12180160 |
| 47 | SCYL2 | 1.11952017 |
| 48 | MAP3K2 | 1.11881734 |
| 49 | LATS2 | 1.11810934 |
| 50 | WNK1 | 1.11272939 |
| 51 | DAPK2 | 1.09474462 |
| 52 | CLK1 | 1.07630283 |
| 53 | TESK1 | 1.07581481 |
| 54 | PRKD2 | 1.07244210 |
| 55 | ERN1 | 1.03476521 |
| 56 | FER | 1.01877518 |
| 57 | PTK6 | 0.99760824 |
| 58 | PIK3CA | 0.96688447 |
| 59 | LIMK1 | 0.93400435 |
| 60 | MAP2K2 | 0.90816141 |
| 61 | NEK1 | 0.90634002 |
| 62 | TAOK2 | 0.90336615 |
| 63 | MAPKAPK5 | 0.90311257 |
| 64 | MARK2 | 0.90121456 |
| 65 | FGFR4 | 0.89637201 |
| 66 | CAMK2D | 0.88611389 |
| 67 | STK38 | 0.88074346 |
| 68 | ROCK2 | 0.87960255 |
| 69 | CDK5 | 0.87628248 |
| 70 | UHMK1 | 0.87599798 |
| 71 | MAP3K3 | 0.87533724 |
| 72 | CAMKK2 | 0.85639590 |
| 73 | PRKD1 | 0.85171483 |
| 74 | PTK2 | 0.84138545 |
| 75 | MAP2K4 | 0.83550635 |
| 76 | PDPK1 | 0.82584228 |
| 77 | PAK2 | 0.82494338 |
| 78 | MUSK | 0.82327951 |
| 79 | BMX | 0.80849246 |
| 80 | CAMK1D | 0.79500960 |
| 81 | ZAP70 | 0.78050828 |
| 82 | MINK1 | 0.77253599 |
| 83 | GSK3A | 0.76052480 |
| 84 | EEF2K | 0.74674611 |
| 85 | CAMK2B | 0.73514787 |
| 86 | ILK | 0.69076638 |
| 87 | FGFR2 | 0.67830800 |
| 88 | MYLK | 0.66204114 |
| 89 | LATS1 | 0.65906927 |
| 90 | PRKG2 | 0.64980509 |
| 91 | PIK3CG | 0.64750434 |
| 92 | AKT2 | 0.64273377 |
| 93 | MAP3K7 | 0.63939281 |
| 94 | ROCK1 | 0.63846458 |
| 95 | CAMK2A | 0.62427666 |
| 96 | NTRK2 | 0.61959481 |
| 97 | DAPK3 | 0.61625557 |
| 98 | MAP2K1 | 0.61008703 |
| 99 | PDK1 | 0.60764407 |
| 100 | IRAK3 | 0.60179300 |
| 101 | PRKCH | 0.59052703 |
| 102 | TAOK1 | 0.58886949 |
| 103 | EPHB2 | 0.58676446 |
| 104 | PDGFRB | 0.58248375 |
| 105 | SIK1 | 0.58113959 |
| 106 | CDK14 | 0.57413256 |
| 107 | CDK15 | 0.57297430 |
| 108 | MAPK12 | 0.56879488 |
| 109 | CDK19 | 0.56186816 |
| 110 | MAP3K1 | 0.55165444 |
| 111 | ARAF | 0.54904309 |
| 112 | CSNK1G2 | 0.54825794 |
| 113 | LRRK2 | 0.53552588 |
| 114 | PKN1 | 0.52240983 |
| 115 | MST1R | 0.52185038 |
| 116 | CAMK2G | 0.50710110 |
| 117 | CDC42BPA | 0.50568196 |
| 118 | MAP3K11 | 0.49561160 |
| 119 | MTOR | 0.49113724 |
| 120 | NME1 | 0.48994663 |
| 121 | CDK11A | 0.47734645 |
| 122 | CAMK1 | 0.47366273 |
| 123 | PRKCE | 0.45066509 |
| 124 | PIM2 | 0.44334862 |
| 125 | MELK | 0.43586430 |
| 126 | ERBB4 | 0.42489557 |
| 127 | MAP4K1 | 0.38978434 |
| 128 | MAPK11 | 0.38363462 |
| 129 | BRSK1 | 0.34961652 |
| 130 | KDR | 0.32473437 |
| 131 | CSNK1D | 0.32020874 |
| 132 | MAP2K3 | 0.29890085 |
| 133 | CSNK1G3 | 0.28970742 |
| 134 | PRKCI | 0.28328055 |
| 135 | CSNK1A1L | 0.25363386 |
| 136 | HIPK2 | 0.20357110 |
| 137 | MAPK14 | 0.20031693 |
| 138 | PINK1 | 0.19596826 |
| 139 | MOS | 0.17691068 |
| 140 | ABL2 | 0.16778872 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 4.84871560 |
| 2 | Sulfur relay system_Homo sapiens_hsa04122 | 3.47968400 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.10530677 |
| 4 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.90164373 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.57227188 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.22928794 |
| 7 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.05963701 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.99736380 |
| 9 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.94662979 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.88251325 |
| 11 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.81180081 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.79349291 |
| 13 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.79114922 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.67697352 |
| 15 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.62262183 |
| 16 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.61187929 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.57938328 |
| 18 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.53102878 |
| 19 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.52129275 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.51249620 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.47514683 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.41308733 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40968375 |
| 24 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.37257475 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.37108792 |
| 26 | Circadian entrainment_Homo sapiens_hsa04713 | 1.36730634 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.36724701 |
| 28 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.35140854 |
| 29 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.34857023 |
| 30 | Insulin secretion_Homo sapiens_hsa04911 | 1.34567618 |
| 31 | GABAergic synapse_Homo sapiens_hsa04727 | 1.34164940 |
| 32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.34042781 |
| 33 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.33207889 |
| 34 | Renin secretion_Homo sapiens_hsa04924 | 1.33166174 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32997657 |
| 36 | Salivary secretion_Homo sapiens_hsa04970 | 1.31747670 |
| 37 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.24361517 |
| 38 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.24126323 |
| 39 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.23858699 |
| 40 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.23833754 |
| 41 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.23053006 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.22613437 |
| 43 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.20846525 |
| 44 | Long-term potentiation_Homo sapiens_hsa04720 | 1.20807021 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.19384450 |
| 46 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.16301741 |
| 47 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.13623869 |
| 48 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.11960260 |
| 49 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.10500767 |
| 50 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.10056531 |
| 51 | Parkinsons disease_Homo sapiens_hsa05012 | 1.09581887 |
| 52 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.09293146 |
| 53 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.08002641 |
| 54 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.07303451 |
| 55 | Alzheimers disease_Homo sapiens_hsa05010 | 1.06206012 |
| 56 | Morphine addiction_Homo sapiens_hsa05032 | 1.03119469 |
| 57 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.03007326 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 1.02533247 |
| 59 | Gap junction_Homo sapiens_hsa04540 | 1.02028145 |
| 60 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.01403100 |
| 61 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.00493045 |
| 62 | Olfactory transduction_Homo sapiens_hsa04740 | 0.99759351 |
| 63 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.99482124 |
| 64 | Leishmaniasis_Homo sapiens_hsa05140 | 0.98263026 |
| 65 | Cocaine addiction_Homo sapiens_hsa05030 | 0.97597869 |
| 66 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.94096046 |
| 67 | Tight junction_Homo sapiens_hsa04530 | 0.93696135 |
| 68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.92030627 |
| 69 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.91788851 |
| 70 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.91763430 |
| 71 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.90764643 |
| 72 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.89099999 |
| 73 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.87167832 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87131233 |
| 75 | Long-term depression_Homo sapiens_hsa04730 | 0.86834929 |
| 76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.86690898 |
| 77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.85667061 |
| 78 | Focal adhesion_Homo sapiens_hsa04510 | 0.84605373 |
| 79 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.83584441 |
| 80 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.83546770 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.83526770 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.83322087 |
| 83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82438687 |
| 84 | Nicotine addiction_Homo sapiens_hsa05033 | 0.80224654 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.79921003 |
| 86 | Axon guidance_Homo sapiens_hsa04360 | 0.78750638 |
| 87 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.76908748 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76061161 |
| 89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.75802578 |
| 90 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.74088829 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73200732 |
| 92 | Bile secretion_Homo sapiens_hsa04976 | 0.73150974 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73098918 |
| 94 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.73074573 |
| 95 | Glioma_Homo sapiens_hsa05214 | 0.72720560 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.72544907 |
| 97 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.72353149 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.70314368 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69857874 |
| 100 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69581525 |
| 101 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.68990848 |
| 102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.67186526 |
| 103 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67110221 |
| 104 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.66834797 |
| 105 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66432450 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65004265 |
| 107 | Melanogenesis_Homo sapiens_hsa04916 | 0.64754681 |
| 108 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.64325145 |
| 109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63802280 |
| 110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63546071 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.63474392 |
| 112 | Taste transduction_Homo sapiens_hsa04742 | 0.63358787 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62745700 |
| 114 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.61460934 |
| 115 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60745341 |
| 116 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.60587368 |
| 117 | ABC transporters_Homo sapiens_hsa02010 | 0.60448673 |
| 118 | * Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60019066 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59618671 |
| 120 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.59405356 |
| 121 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.54542921 |
| 122 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54212956 |
| 123 | Prostate cancer_Homo sapiens_hsa05215 | 0.53690462 |
| 124 | Huntingtons disease_Homo sapiens_hsa05016 | 0.53455180 |
| 125 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.52050307 |
| 126 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.51283187 |
| 127 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51264535 |
| 128 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51172149 |
| 129 | Insulin resistance_Homo sapiens_hsa04931 | 0.50813483 |
| 130 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.50168942 |
| 131 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49710143 |
| 132 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49621969 |
| 133 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.49113735 |
| 134 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48565717 |
| 135 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.45876681 |
| 136 | Lysosome_Homo sapiens_hsa04142 | 0.43931753 |
| 137 | Bladder cancer_Homo sapiens_hsa05219 | 0.43355241 |
| 138 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43031776 |
| 139 | Amoebiasis_Homo sapiens_hsa05146 | 0.41459467 |
| 140 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.41302850 |
| 141 | Phagosome_Homo sapiens_hsa04145 | 0.40280002 |
| 142 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.38086245 |
| 143 | Prion diseases_Homo sapiens_hsa05020 | 0.37537942 |
| 144 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36950518 |
| 145 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35859696 |
| 146 | Pathways in cancer_Homo sapiens_hsa05200 | 0.34103643 |
| 147 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32327062 |
| 148 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.30468514 |

